This commentary refers to 'Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis', by E.P. Navarese et al., https:// doi.org/10.1093/eurheartj/ehab246; 'When a meta-analysis equals a single large-scale trial with meaningful follow-up', by E.P. Navarese et al., https://doi:10.1093/eurheartj/ ehab460; and the discussion pieces 'Cardiac death should be the primary endpoint for revascularisation trials and meta analyses', by H.D. White, https://doi.org/10.1093/ eurheartj/ehab676; `In the pool: dilution or drowning?'
Navarese, E. P., Andreotti, F., Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes, <<EUROPEAN HEART JOURNAL>>, 2021; 42 (45): 4699-4700. [doi:10.1093/eurheartj/ehab677] [http://hdl.handle.net/10807/206845]